Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Jan 2;19(1):e0296432.
doi: 10.1371/journal.pone.0296432. eCollection 2024.

COVID-19 vaccine hesitancy among healthcare workers in Arab Countries: A systematic review and meta-analysis

Affiliations
Meta-Analysis

COVID-19 vaccine hesitancy among healthcare workers in Arab Countries: A systematic review and meta-analysis

Mai Alalawi et al. PLoS One. .

Abstract

Background: Vaccine hesitancy is a major obstacle to the large efforts made by governments and health organizations toward achieving successful COVID-19 vaccination programs. Healthcare worker's (HCWs) acceptance or refusal of the vaccine is an influencing factor to the attitudes of their patients and general population. This study aimed to report the acceptance rates for COVID-19 vaccines among HCWs in Arab countries and identify key factors driving the attitudes of HCWs in the Arab world toward vaccines.

Methods: This systematic review and meta-analysis followed the PRISMA guidelines. PubMed and Scopus databases were searched using pre-specified keywords. All cross-sectional studies that assessed COVID-19 vaccine hesitancy and/or acceptance among HCWs in Arab countries until July 2022, were included. The quality of the included studies and the risk of bias was assessed using the JBI critical appraisal tool. The pooled acceptance rate of the COVID-19 vaccine was assessed using a random-effects model with a 95% confidence interval.

Results: A total of 861 articles were identified, of which, 43 were included in the study. All the studies were cross-sectional and survey-based. The total sample size was 57,250 HCWs and the acceptance rate of the COVID-19 vaccine was 60.4% (95% CI, 53.8% to 66.6%; I2, 41.9%). In addition, the COVID-19 vaccine acceptance rate among males was 65.4% (95% CI, 55.9% to 73.9%; I2, 0%) while among females was 48.2% (95% CI, 37.8% to 58.6%; I2, 0%). The most frequently reported factors associated with COVID-19 vaccine acceptance were being male, higher risk perception of contracting COVID-19, positive attitude toward the influenza vaccine, and higher educational level. Predictors of vaccine hesitancy most frequently included concerns about COVID-19 vaccine safety, living in rural areas, low monthly income, and fewer years of practice experience.

Conclusion: A moderate acceptance rate of COVID-19 vaccines was reported among HCWs in the Arab World. Considering potential future pandemics, regulatory bodies should raise awareness regarding vaccine safety and efficacy and tailor their efforts to target HCWs who would consequently influence the public with their attitude towards vaccines.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. PRISMA flowchart of literature search and review.
Fig 2
Fig 2. The overall acceptance rate of COVID-19 vaccines among Arab countries.
Fig 3
Fig 3. The acceptance rate of COVID-19 vaccines by country.
Fig 4
Fig 4. COVID-19 vaccine acceptance stratified by sex.
(A) males (B) females.

Similar articles

Cited by

References

    1. Pogue K, Jensen JL, Stancil CK, Ferguson DG, Hughes SJ, Mello EJ, et al.. Influences on attitudes regarding potential covid‐19 vaccination in the united states. Vaccines. 2020;8: 1–14. doi: 10.3390/vaccines8040582 - DOI - PMC - PubMed
    1. Lynch HJ, Marcuse EK. Vaccines and immunization. In: The Social Ecology of Infectious Diseases. 2007. pp. 275–299. doi: 10.1016/B978-012370466-5.50015-7 - DOI
    1. Friedrich MJ. WHO’s Top Health Threats for 2019. Jama. 2019;321: 1041. doi: 10.1001/jama.2019.1934 - DOI - PubMed
    1. MacDonald NE, Eskola J, Liang X, Chaudhuri M, Dube E, Gellin B, et al.. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;33: 4161–4164. doi: 10.1016/j.vaccine.2015.04.036 - DOI - PubMed
    1. Palache A, Oriol-Mathieu V, Abelin A, Music T. Seasonal influenza vaccine dose distribution in 157 countries (2004–2011). Vaccine. 2014;32: 6369–6376. doi: 10.1016/j.vaccine.2014.07.012 - DOI - PubMed

Substances